Peptide Amphiphile Micelles Self-Adjuvant Group A Streptococcal Vaccination

AAPS Journal

Volumn 17, Issue 2, 2015, Pages 380-388

  Trent, Amanda ^a   Ulery, Bret D ^b,c   Black, Matthew J ^d   Barrett, John C ^c,e   Liang, Simon ^e   Kostenko, Yulia ^f   David, Natalie A ^e   Tirrell, Matthew V ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d University of California   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f University of California   (United States)

Author keywords

group A streptococcus; J8 peptide; peptide amphiphile micelles; self adjuvant; vaccine

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; MICELLE; PEPTIDE; STREPTOCOCCUS VACCINE;

ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICELLE; MOUSE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; DRUG DELIVERY SYSTEMS; FEMALE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICELLES; PEPTIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES;

EID: 84939937305     PISSN: None     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-014-9707-3     Document Type: Article

References (61)

1. Tart AH, Walker MJ, Musser JM. New understanding of the group A streptococcus pathogenesis cycle. Trends Microbiol. 2007;15(7):318–25.
2. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94.
3. Eison TM, Ault BH, Jones DP, Chesney RW, Wyatt RJ. Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol. 2011;26(2):165–80.
4. Lawrence RS. Vaccines for the 21st century: a tool for decision making. Washington, D.C.: National Academies Press; 2000.
5. Steer AC, Batzloff MR, Mulholland K, Carapetis JR. Group A streptococcal vaccines: facts versus fantasy. Curr Opin Infect Dis. 2009;22(6):544–52.
6. Sagar V, Bergmann R, Nerlich A, McMillan DJ, Nitsche-Schmitz DP, Chhatwal GS. Variability in the distribution of genes encoding virulence factors and putative extracellular proteins of Streptococcus pyogenes in India, a region with high streptococcal disease burden, and implication for development of a regional multisubunit vaccine. Clin Vaccine Immunol. 2012;19(11):1818–25.
7. Persson J, Beall B, Linse S, Lindahl G. Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog. 2006;2(5):e47.
8. Lymbury RS, Olive C, Powell KA, Good MF, Hirst RG, LaBrooy JT, et al. Induction of autoimmune valvulitis in Lew rats following immunization with peptides from the conserved region of group A streptococcal M protein. J Autoimmun. 2003;20(3):211–7.
9. Olive C, Sun HK, Ho MF, Dyer J, Horvath A, Toth I, et al. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. J Infect Dis. 2006;194(3):316–24.
10. Pandey M, Wykes MN, Hartas J, Good MF, Batzloff MR. Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help. J Immunol. 2013;190(6):2692–701.
11. Relf WA, Cooper J, Brandt ER, Hayman WA, Anders RF, Pruksakorn S, et al. Mapping a conserved conformational epitope from the M protein of group A streptococci. Pept Res. 1996;9(1):12–20.
12. Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol. 1997;9(11):1723–33.
13. Black M, Trent A, Tirrell M, Olive C. Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines. 2010;9(2):157–73.
14. Simerska P, Abdel-Aal AB, Fujita Y, Moyle PM, McGeary RP, Olive C, et al. Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines. J Med Chem. 2008;51(5):1447–52.
15. Middelberg AP, Rivera-Hernandez T, Wibowo N, Lua LH, Fan Y, Magor G, et al. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine. 2011;29(41):7154–62.
16. Pandey M, Batzloff MR, Good MF. Mechanism of protection induced by group A streptococcus vaccine candidate J8-DT: contribution of B and T-cells toward protection. PLoS One. 2009;4(4):e5147.
17. Azmi F, Fuaad AAA, Skwarczynski M, Toth I. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccines Immunother. 2013;10(3):27332.
18. Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, et al. Nanoparticle vaccines. Vaccine. 2014;32(3):327–37.
19. Webber MJ, Tongers J, Newcomb CJ, Marquardt KT, Bauersachs J, Losordo DW, et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci U S A. 2011;108(33):13438–43.
20. Mammadov R, Mammadov B, Toksoz S, Aydin B, Ragci Y, Tekinay AB, et al. Heparin mimetic peptide nanofibers promote angiogenesis. Biomacromolecules. 2011;12(10):3508–19.
21. Anderson JM, Kushwaha M, Tambralli A, Bellis SL, Camata RP, Jun HW. Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix. Biomacromolecules. 2009;10(10):2935–44.
22. Mata A, Geng Y, Henrikson KJ, Aparicio C, Stock SR, Satcher RL, et al. Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix. Biomaterials. 2010;31(23):6004–12.
23. Song Y, Li Y, Zheng Q, Wu K, Guo X, Wu Y, et al. Neural progenitor cells survival and neuronal differentiation in peptide-based hydrogels. J Biomater Sci Polym Ed. 2011;22(4–6):475–87.
24. Angeloni NL, Bond CW, Tang Y, Harrington DA, Zhang S, Stupp SI, et al. Regeneration of the cavernous nerve by Sonic hedgehog using aligned peptide amphiphile nanofibers. Biomaterials. 2011;32(4):1091–101.
25. Peters D, Kastantin M, Kotamraju VR, Karmali PP, Gujraty K, Tirrell M, et al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A. 2009;106(24):9815–9.
26. Missirlis D, Krogstad DV, Tirrell M. Internalization of p53(14–29) peptide amphiphiles and subsequent endosomal disruption results in SJSA-1 cell death. Mol Pharm. 2010;7(6):2173–84.
27. Standley SM, Toft DJ, Cheng H, Soukasene S, Chen J, Raja SM, et al. Induction of cancer death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res. 2010;70(8):3020–6.
28. Lim DJ, Antipenko SV, Anderson JM, Jaimes KF, Viera L, Stephen BR, et al. Enhanced rat islet function and survival in vitro using a biomimetic self-assembled nanomatrix gel. Tissue Eng A. 2011;17(3–4):399–406.
29. Khan S, Sur S, Newcomb CJ, Appelt EA, Stupp SI. Self-assembling glucagon-like peptide 1-mimetic peptide amphiphiles for enhanced activity and proliferation of insulin-secreting cells. Acta Biomater. 2012;8(5):1685–92.
30. Boato F, Thomas RM, Ghasparian A, Freund-REnard A, Moehle K, Robinson JA. Synthetic virus-like particles from self-assembling coiled-coil lipopeptides and their use in antigen display to the immune system. Angew Chem Int Ed. 2007;46(47):9015–8.
31. Lee KC, Carlson PA, Goldstein AS, Yager P, Gelb MH. Protection of a decapeptide from proteolytic cleavage by lipidation and self-assembly into high-axial-ratio microstructures: a kinetic and structural study. Langmuir. 1999;15(17):5500–8.
32. Missirlis D, Khant H, Tirrell M. Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro. Biochemistry. 2009;48(15):3304–14.
33. Black M, Trent A, Kostenko Y, Lee JS, Olive C, Tirrell M. Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo. Adv Mater. 2012;24(28):3845–9.
34. Berndt P, Fields GB, Tirrell M. Synthetic lipidation of peptides and amino acids: monolayer structure and properties. J Am Chem Soc. 1995;117(37):9515–22.
35. Kastantin M, Ananthanarayanan B, Karmali P, Ruoslahti E, Tirrell M. Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles. Langmuir. 2009;25(13):7279–86.
36. Mlinar LB, Chung EJ, Wonder EA, Tirrell M. Active targeting of early and mid-stage atherosclerosis plaques using self-assembled peptide amphiphile micelles. BIomaterials. 2014;35(30):8678–86.
37. Greenfield NJ, Fasman GD. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry. 1969;8(10):4108–16.
38. Skwarcynski M, Kamaruzaman KA, Srinivasan S, Zaman M, Lin IC, Batzloff MR, et al. M-protein-derived conformational peptide epitope vaccine candidate against group A streptococcus. Curr Drug Deliv. 2013;10(1):39–45.
39. Jackson DC, Lau YF, Le T, Suhrbier A, Deliyannis G, Cheers C, et al. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc Natl Acad Sci U S A. 2004;101(43):15440–5.
40. Pashuck ET, Stupp SI. Direct observation of morphological transformation from twisted ribbons into helical ribbons. J Am Chem Soc. 2010;132(26):8819–21.
41. Gore T, Dori Y, Talmon Y, Tirrell M, Biance-Peled H. Self-assembly of model collagen peptide amphiphiles. Langmuir. 2001;17(17):5352–60.
42. Shimada T, Lee S, Bates FS, Hotta A, Tirrell M. Wormlike micelle formation in peptide-lipid conjugates driven by secondary structure transformation of the headgroups. J Phys Chem B. 2009;113(42):13711–4.
43. Ghendon Y, Markushin S, Akopova I, Koptiaeva I, Krivtsov G. Chitosan as an adjuvant for poliovaccine. J Med Virol. 2011;83(5):847–52.
44. Allard-Vannier E, Cohen-Jonathan S, Gautlier J, Herve-Aubert K, Munnier E, Souce M, et al. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo. Eur J Pharm Biopharm. 2012;81(3):498–505.
45. Narayanan D, Anitha A, Jayakumar R, Nair SV, Chennazhi KP. Synthesis, characterization and preliminary in vitro evaluation of PTH 1–34 loaded chitosan nanoparticles for osteoporosis. J Biomed Nanotechnol. 2012;8(1):98–106.
46. Gosens I, Post JA, Fonteyne LJDL, Jansen EH, Geus JW, Cassee FR, et al. Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation. Part Fibre Toxicol. 2010;7(1):37.
47. Wu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, et al. Development of multinuclear polymeric nanoparticles as robust protein nanocarriers. Angew Chem Int Ed. 2014;53(34):8975–9.
48. Yao B, Zheng D, Liang S, Zhang C. Conformational B-cell epitope prediction on antigen protein structures: a review of current algorithms and comparison with common binding site prediction methods. PLoS One. 2013;8(4):e62249.
49. McNamara C, Zinkernagel AS, Macheboeuf P, Cunningham MW, Nizet V, Ghosh P. Coiled-coil irregularities and instabilities in group A streptococcus M1 are required for virulence. Science. 2008;319(5868):1405–8.
50. Tu RS, Marullo R, Pynn R, Bitton R, Bianco-Peled H, Tirrell MV. Cooperative DNA binding and assembly by a bZip peptide-amphiphile. Soft Matter. 2010;6:1035–44.
51. Trent A, Marullo R, Lin B, Black M, Tirrell M. Structural properties of soluble peptide amphiphile micelles. Soft Matter. 2011;7:9572–82.
52. Marullo R, Kastantin M, Drews LB, Tirrell M. Peptide contour length determines equilibrium secondary structure in protein-analogous micelles. Biopolymers. 2013;99(9):573–81.
53. Hansmann UHE, Masuya M, Okamoto Y. Characteristic temperatures of folding of a small peptide. Proc Natl Acad Sci U S A. 1997;94(20):10652–6.
54. Nagarajan R. Molecular packing parameter and surfactant self-assembly: the neglected role of the surfactant tail. Langmuir. 2002;18(1):31–8.
55. Satoh M, Kuroda Y, Yoshida H, Behney KM, Mizutani A, Akaogi J, et al. Induction of lupus autoantibodies by adjuvants. J Autoimmun. 2003;21(1):1–9.
56. Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother. 2004;58(5):325–37.
57. Hailemichael Y, Dai Z, Jaffarzad N, Ye Y, Medina MA, Huang X-F, et al. Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion. Nat Med. 2013;19(4):465–72.
58. Schunk MK, Macallum GE. Applications and optimization of immunization procedures. ILAR J. 2005;46(3):241–57.
59. Zaman M, Abdel-Aal AB, Fujita Y, Phillipps KS, Batzloff MR, Good MF, et al. Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship. PLoS One. 2012;7(1):e30146.
60. Rudra JS, Tian YF, Jung JP, Collier JH. A self-assembling peptide acting as an immune adjuvant. Proc Natl Acad Sci U S A. 2010;107(2):622–7.
61. Chen J, Pompano RR, Santiago FW, Maillat L, Sciammas R, Sun T, et al. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. Biomaterials. 2013;34(34):8776–85.